Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes

Infection and Immunity

Volumn 65, Issue 3, 1997, Pages 858-864

  Weidemann, B ^a   Schletter, J ^a   Dziarski, R ^b   Kusumoto, S ^c   Stelter, F ^d   Rietschel, E T ^a   Flad, H D ^a   Ulmer, A J ^a,e  

^a Center for Mediane and Biosciences   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c INDIANA UNIVERSITY NORTHWEST   (United States)

^d OSAKA UNIVERSITY   (Japan)

^e RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ISOTHIOCYANIC ACID; MONOCLONAL ANTIBODY; MURAMYL DIPEPTIDE; PEPTIDOGLYCAN;

ARTICLE; BINDING AFFINITY; CELL WALL; ELECTROPHORETIC MOBILITY; GRAM POSITIVE BACTERIUM; MONOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; SEPSIS; STRUCTURE ACTIVITY RELATION;

EID: 0031019652     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.3.858-864.1997     Document Type: Article

References (49)

1. Bazil, V., M. Baudys, I. Hilgert, I. Stefanova, M. G. Low, J. Zbrozek, and V. Horejsi. 1989. Structural relationship between the soluble and membranebound forms of human monocyte surface glycoprotein CD14. Mol. Immunol. 26:657-662.
2. Bazil, V., V. Horejsi, ML Baudys, H. Kristofova, J. L. Strominger, W. Kostka, and I. Hilgert. 1986. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16:1583-1589.
3. Bone, R. C. 1994. Gram-positive organisms and sepsis. Arch. Intern. Med. 154:26-34.
4. Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21:77-89.
5. Chatterjee, D., A. D. Roberts, K. Lowell, P. J. Brennan, and I. M. Orme. 1992. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 60:1249-1253.
6. Dinarello, C. A. 1988. Biology of interleukin 1. FASEB J. 2:108-115.
7. 2+. Cell. Immunol. 111:10-27.
8. Dziarski, R. 1991. Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J. Biol. Chem. 266: 4713-4718.
9. Dziarski, R. 1991. Peptidoglycan and lipopolysaccharide bind to the same binding site on lymphocytes. J. Biol. Chem. 266:4719-4725.
10. Dziarski, R. 1994. Cell-bound albumin is the 70-kDa peptidoglycan, lipopolysaccharide, and lipoteichoic acid-binding protein on lymphocytes and macrophages. J. Biol. Chem. 269:20431-20436.
11. 2-terminal kinase mitogen activated protein kinases by bacterial peptidoglycan. J. Infect. Dis. 174:777-785.
12. Espevik, T., M. Otterlei, G. Skjak, B. L. Ryan, S. D. Wright, and A. Sundan. 1993. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 23:255-261.
13. Feist, W., A. J. Ulmer, M. H. Wang, J. Musehold, C. Schlüter, J. Gerdes, H. Herzbeck, H. Brade, S. Kusumoto, T. Diamantstein, E. T. Rietschel, and H.-D. Flad. 1992. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor la of lipid A. FEMS Microbiol. Immunol. 89:73-90.
14. Flad, H.-D., H. Loppnow, E. T. Rietschel, and A. J. Ulmer. 1993. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187:303-316.
15. Galanos, C., O. Lüderitz, and O. Westphal. 1979. Preparation and properties of a standard lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentralbl. Bakteriol. Abt. 1 Orig. A 243:226-244.
16. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032.
17. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310-23316.
18. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269-277.
19. Heumann, D., C. Barras, A. Severin, M. P. Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:2715-2721.
20. Imoto, M., H. Yoshimura, M. Yamamoto, T. Shimamoto, S. Kusumoto, and T. Shiba. 1987. Chemical synthesis of a biosynthetic precursor of lipid A with a phosphorylated tetraacyldisaccharide structure. Bull. Chem. Soc. Jpn. 60: 2197-2204.
21. Jirik, F. R., T. J. Podor, T. Hirano, T. Kishimoto, D. J. Loskutoff, D. A. Carson, and M. Lotz. 1989. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142:144-147.
22. Kawahara, K., U. Seydel, M. Matsuura, H. Danbara, E. T. Rietschel, and U. Zähringer. 1991. Chemical structure of glycosphingolipids isolated from Sphingomonus paucimobilis. FEBS Lett. 292:107-110.
23. Kirikae, T., F. U. Schade, U. Zähringer, F. Kirikae, H. Brade, T. Kusama, and E. T. Rietschel. 1994. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction. FEMS Immunol. Med. Microbiol. 8:13-26.
24. Kirkland, T. N., F. Finley, D. Leturcp, A. Moriarty, J.-D. Lee, R. J. Ulevitch, and P. S. Tobias. 1993. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 268:24818-24823.
25. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites on the LPS recognition pathway. J. Biol. Chem. 270:9904-9910.
26. Krziwon, C., U. Zähringer, K. Kawahara, B. Weidemann, S. Kusumoto, E. T. Rietschel, H.-D. Flad, and A. J. Ulmer. 1995. Glycosphingolipids from Sphin gomonas paucimobilis induce monokine production in human mononuclear cells. Infect. Immun. 63:2899-2905.
27. Kusumoto, S., Y. Tarumi, K. Ikenaka, and T. Shiba. 1976. Chemical synthesis of N-acetylmuramyl peptides with partial structures of bacterial cell wall and their analogs in relation to immunoadjuvant activities. Bull. Chem. Soc. Jpn. 49:533-539.
28. Kusunoki, T., E. Hailman, T. S. C. Juan, H. S. Lichenstein, and S. D. Wright. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182:1673-1682.
29. Lei, M.-G., and D. C. Morrison. 1988. Specific endotoxic lipopolysaccharidebinding proteins on murine splenocytes. I. Detection of lipopolysaccbaridebinding sites on splenocytes and splenocyte subpopulations. J. Immunol. 141:946-1005.
30. Mathison, J., P. Tobias, and E. Wolfson. 1991. Regulatory mechanisms of host responsiveness to endotoxin (lipopolysaccharide). Pathol. Biol. 59:185-188.
31. Mathison, J., P. Tobias, and E. Wolfson. 1992. Plasma lipopolysaccharide (LPS)-binding protein. J. Immunol. 149:200-206.
32. Mattsson, E., L. Verhage, J. Rollof, A. Fleer, J. Verhoef, and H. van Dijk. 1993. Peptidoglycan and teiehoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumor necrosis factor-α, interleukin-1β and interleukin-6. FEMS Immunol. Med. Microbiol. 7:281-288.
33. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. 65:55-65.
34. Pugin, J., D. Heumann, A. Tomasz, V. Kravchenko, Y. Akamatzu, M. Nishijima, M. Glauder, P. Tobias, and R. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunology 1:509-516.
35. Rietschel, E. T., H. Brade, O. Holst, L. Brade, S. Müller-Loennies, U. Mamat, U. Zähringer, F. Beckmann, U. Seydel, K. Brandenburg, A. J. Ulmer, T. Mattern, H. Heine, J. Schletter, S. Hauschildt, H. Loppnow, U. Schönbeck, H.-D. Flad, U. F. Schade, F. Di Padova, S. Kusumoto, and R. R. Schumann. 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response and immunological detoxification. Curr. Top. Microbiol. Immunol. 216:39-81.
36. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91:72S-75S.
37. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
38. Schutt, C., S. Witt, U. Grunwald, F. Stelter, T. Schilling, X. Fan, B.-P. Masrquart, S. Bassarab, and C- Krüger. 1995. Epitope mapping of CD14 glycoprotein, p. 785-788. In S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, and R. F. Todd (ed.). Leucocyte typing. V. White cell differentiation antigens. Oxford University Press, Oxford, United Kingdom.
39. Skelly. R. R., P. Munkenbeck, and D. C. Morrison. 1979. Stimulation of T-independe antibody responses by hapten-lipopolysaccha rides without repeating polymeric structure. Infect. Immun. 23:287-293.
40. Steiler, F., M. Pfister, M. Bernheiden, R. S. Jack, P. Butler, H. Engelmann, and C. Schütt. 1996. The myeloid differentiation antigen CDU14 is N- and O-glycosylated: contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur. J. Biochem. 236:457-464.
41. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1986. Isolation of a lipopolysaccharide binding acute phase reactant from rabbit serum. J. Exp. Med. 164:777-793.
42. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1989. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264:10867.
43. Ulmer, A. J., H. Heine, W. Feist, S. Kusumoto, T. Kusama, H. Brade, U. Schade, E. T. Rietschel, and H.-D. Flad. 1992. Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures. Infect. Immun. 60:3309-3314.
44. Vogel, S. N., and M. M. Hogan. 1990. Immunopharmacology - the role of cells and cytokines in immunity and inflammation. Oxford University Press, New York, N.Y.
45. Wang, M.-H., H.-D. Flad, W. Feist, H. Brade, S. Kusumoto, E. T. Rietschel, and A. J. Ulmer. 1991. Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells. Infect. Immun. 59:4655-4664.
46. Wang, M.-H., H.-D. Flad, W. Feist, J. Musehold, S. Kusomoto, H. Brade, J. Gerdes, E. T. Rietschel, and A. J. Ulmer. 1992. Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 11:23-31.
47. Weidemann, B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H.-D. Flad, and A. J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62:4709-4715.
48. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
49. Wright, S. D., P. S. Tobias, R. J. Ulevitch, and R. A. Ramos. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170:1231-1247.